PMV Pharmaceuticals, Inc.
PMVP· Nasdaq
PMV Pharmaceuticals, Inc.
- Last sale
- Oct 1, 2026 · +4.79%
- Market cap
- $93.55M
- 53.46M shares
- Filings
- 387
Price
Oct 1, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Research And Development
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $69,877,000 | reported | |
| FY 2024 | 2024-12-31 | $58,527,000 | reported | |
| FY 2023 | 2023-12-31 | $55,885,000 | reported | |
| FY 2022 | 2022-12-31 | $51,988,000 | reported | |
| FY 2021 | 2021-12-31 | $36,493,000 | reported | |
| FY 2020 | 2020-12-31 | $23,933,000 | reported | |
| FY 2019 | 2019-12-31 | $20,759,000 | reported | |
| FY 2018 | 2018-12-31 | $13,853,000 | reported |
PMV Pharmaceuticals, Inc. · CIK 1699382 · Engraved from SEC EDGAR
